JLVIX | VSTSX | JLVIX / VSTSX | |
Total Expense Ratio | 0.77 | 0.01 | 7,700% |
Annual Report Gross Expense Ratio | 0.78 | 0.01 | 7,800% |
Fund Existence | 25 years | 9 years | - |
Gain YTD | 7.392 | 13.029 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.22B | 2.02T | 0% |
Annual Yield % from dividends | 0.47 | 1.15 | 41% |
Returns for 1 year | -1.79 | 13.82 | -13% |
Returns for 3 years | 36.94 | 76.16 | 49% |
Returns for 5 years | 36.09 | 85.01 | 42% |
Returns for 10 years | 82.83 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VCINX | 13.93 | 0.11 | +0.80% |
VALIC Company I International Growth | |||
RYOAX | 61.53 | 0.24 | +0.39% |
Rydex Biotechnology H | |||
CCALX | 71.40 | 0.01 | +0.01% |
Conestoga Small Cap Institutional | |||
DFIEX | 19.49 | -0.02 | -0.10% |
DFA International Core Equity 2 I | |||
PEXMX | 36.24 | -0.06 | -0.17% |
T. Rowe Price Extended Equity Market Idx |